.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Mesna - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for mesna?

Mesna is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Sagent Pharms, West-ward Pharms Int, Baxter Hlthcare, Mylan Labs Ltd, Teva Pharms Usa, and Mylan Institutional, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for mesna. Six suppliers are listed for this compound.

Summary for Generic Name: mesna

Tradenames:2
Patents:1
Applicants:7
NDAs:8
Drug Master File Entries: see list10
Suppliers / Packagers: see list6
Bulk Api Vendors: see list72
Clinical Trials: see list77
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mesna at DailyMed

Pharmacology for Ingredient: mesna

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
MESNA
mesna
INJECTABLE;INTRAVENOUS075764-001Apr 27, 2001RXNoNo► Subscribe► Subscribe
West-ward Pharms Int
MESNA
mesna
INJECTABLE;INTRAVENOUS075739-001Jan 9, 2004RXNoNo► Subscribe► Subscribe
Sagent Pharms
MESNA
mesna
INJECTABLE;INTRAVENOUS090913-001Apr 13, 2010RXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
MESNA
mesna
INJECTABLE;INTRAVENOUS203364-001Jul 18, 2014RXNoNo► Subscribe► Subscribe
Mylan Institutional
MESNA
mesna
INJECTABLE;INTRAVENOUS076488-001Mar 8, 2012RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mesna

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
MESNEX
mesna
TABLET;ORAL020855-001Mar 21, 20025,252,341► Subscribe
Baxter Hlthcare
MESNEX
mesna
TABLET;ORAL020855-001Mar 21, 20025,262,169► Subscribe
Baxter Hlthcare
MESNEX
mesna
INJECTABLE;INTRAVENOUS019884-001Dec 30, 19885,696,172► Subscribe
Baxter Hlthcare
MESNEX
mesna
INJECTABLE;INTRAVENOUS019884-001Dec 30, 19884,220,660► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc